ERBB2 and triple-negative breast carcinoma: The triple-negative breast cancer (TNBC) subclass accounts for 15 - 20% of all BCs and does not express the estrogen receptor (ER), progesterone receptor (PR), or human epidermal growth factor receptor 2 (Her-2).